NCT02104921View on ClinicalTrials.gov

Innovative Ultrasound Technology in Neuromuscular Disease

CompletedOBSERVATIONAL
Enrollment

223

Participants

Timeline

Start Date

December 1, 2013

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Amyotrophic Lateral SclerosisMuscular DystrophyRadiculopathyMyopathyPolyneuropathy and MononeuropathiesTrauma InjuryOrthopedic Disorder
Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER

NCT02104921 - Innovative Ultrasound Technology in Neuromuscular Disease | Biotech Hunter | Biotech Hunter